DK1333812T3 - Mikrogranulat baseret på aktivt stof og fremgangsmåde til at fremstille samme - Google Patents

Mikrogranulat baseret på aktivt stof og fremgangsmåde til at fremstille samme

Info

Publication number
DK1333812T3
DK1333812T3 DK01996363T DK01996363T DK1333812T3 DK 1333812 T3 DK1333812 T3 DK 1333812T3 DK 01996363 T DK01996363 T DK 01996363T DK 01996363 T DK01996363 T DK 01996363T DK 1333812 T3 DK1333812 T3 DK 1333812T3
Authority
DK
Denmark
Prior art keywords
preparing
same
active substance
core
microgranules
Prior art date
Application number
DK01996363T
Other languages
English (en)
Inventor
Etienne Bruna
Edouard Gendrot
Gerard Cousin
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Application granted granted Critical
Publication of DK1333812T3 publication Critical patent/DK1333812T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micromachines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01996363T 2000-11-16 2001-11-15 Mikrogranulat baseret på aktivt stof og fremgangsmåde til at fremstille samme DK1333812T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0014803A FR2816507B1 (fr) 2000-11-16 2000-11-16 Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
PCT/FR2001/003584 WO2002039981A1 (fr) 2000-11-16 2001-11-15 Microgranules a base de principe actif et leur procede de fabrication

Publications (1)

Publication Number Publication Date
DK1333812T3 true DK1333812T3 (da) 2008-03-31

Family

ID=8856551

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01996363T DK1333812T3 (da) 2000-11-16 2001-11-15 Mikrogranulat baseret på aktivt stof og fremgangsmåde til at fremstille samme

Country Status (15)

Country Link
US (1) US7829122B2 (da)
EP (1) EP1333812B1 (da)
JP (1) JP4234427B2 (da)
CN (1) CN1222277C (da)
AT (1) ATE387187T1 (da)
AU (2) AU2002223074B2 (da)
CA (1) CA2427899C (da)
DE (1) DE60133028T2 (da)
DK (1) DK1333812T3 (da)
ES (1) ES2300384T3 (da)
FR (1) FR2816507B1 (da)
HK (1) HK1063017A1 (da)
MX (1) MXPA03004300A (da)
PT (1) PT1333812E (da)
WO (1) WO2002039981A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
ATE346590T1 (de) * 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
FR2831820B1 (fr) * 2001-11-05 2004-08-20 Ethypharm Sa Comprime orodispersible presentant une grande homogeneite et son procede de preparation
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2850576B1 (fr) * 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
CN1893956A (zh) * 2003-07-25 2007-01-10 沃纳奇尔科特公司 多西环素金属络合物固体剂型
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
HUE030388T2 (en) 2004-11-24 2017-05-29 Meda Pharmaceuticals Inc Preparations and methods of use containing azelastine
US20060183719A1 (en) * 2005-01-21 2006-08-17 Devries Tina M Tetracycline metal complex in a solid dosage form
CN101912360A (zh) * 2010-07-13 2010-12-15 山东达因海洋生物制药股份有限公司 布洛芬混悬液及其制备方法
BR112013020404B1 (pt) 2011-02-11 2022-04-05 Société Des Produits Nestlé S.A Formulação de multiparticulado de lmentol, seu método de produção, ecomposição de multiparticulado
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
DE102012007671A1 (de) 2012-04-16 2013-10-17 Acino Pharma Ag Pellets mit hohem Wirkstoffgehalt
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
WO2014175852A1 (en) 2013-04-23 2014-10-30 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
KR102019645B1 (ko) * 2019-02-21 2019-09-09 한국화학연구원 염기성오염물질 제거용 비드 및 이의 제조방법
CN111184694A (zh) * 2020-01-19 2020-05-22 广东青云山药业有限公司 一种口腔速溶颗粒的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
IT1115596B (it) 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
JP3078859B2 (ja) 1990-02-23 2000-08-21 武田薬品工業株式会社 安定な放出制御性製剤用コーティング剤
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
DK0744941T3 (da) 1994-02-16 2003-09-29 Abbott Lab Fremgangsmåde til fremstilling af findelte farmaceutiske formuleringer
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Also Published As

Publication number Publication date
FR2816507A1 (fr) 2002-05-17
PT1333812E (pt) 2008-03-17
CA2427899A1 (fr) 2002-05-23
JP2004517064A (ja) 2004-06-10
AU2307402A (en) 2002-05-27
ATE387187T1 (de) 2008-03-15
US20040101568A1 (en) 2004-05-27
US7829122B2 (en) 2010-11-09
EP1333812A1 (fr) 2003-08-13
CN1222277C (zh) 2005-10-12
EP1333812B1 (fr) 2008-02-27
DE60133028D1 (de) 2008-04-10
FR2816507B1 (fr) 2003-02-28
MXPA03004300A (es) 2004-09-10
CA2427899C (fr) 2011-05-10
HK1063017A1 (en) 2004-12-10
AU2002223074B2 (en) 2005-03-10
DE60133028T2 (de) 2009-03-12
JP4234427B2 (ja) 2009-03-04
ES2300384T3 (es) 2008-06-16
CN1481235A (zh) 2004-03-10
WO2002039981A1 (fr) 2002-05-23

Similar Documents

Publication Publication Date Title
DK1333812T3 (da) Mikrogranulat baseret på aktivt stof og fremgangsmåde til at fremstille samme
ES2052458B1 (es) Formulacion estable de microgranulos de omeprazol gastroprotegidos y procedimiento para su obtencion.
DE69725601D1 (de) Sphärische halbleiteranordnung, verfahren zu seiner herstellung und sphärisches halbleiteranordnungmaterial
ES2141380T3 (es) Metodo para la fabricacion de un comprimido recubierto, con nucleo puntiagudo.
PT1051174E (pt) Microgranulos de omeprazole gastroprotegidos processo para os obter e preparacoes farmaceuticas
ES2157731A1 (es) Preparacion farmaceutica oral de un compuesto de anticidad antifungica y procedimiento para su preparacion.
IT1299982B1 (it) Metodo per la realizzazione di pacchetti di sigarette ed impianto per l'attuazione di tale metodo.
HUP0002729A3 (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
TR28559A (tr) Toprak muamelesi icin termit kontrol terkibi.
IT9022088A0 (it) 1,3-bis(3-(mono o poliidrossi)acilamino-5-(mono o poliirossi-al-chil)aminocarbonil-2,4,6-triiodo-benzoil-amino)-idrossi- o idrossi-alchil-propani, loro metodo di preparazione e mezzi di contrasto roentgenografici che li contengono.
GB2343117A (en) Benzimidazole pharmaceutical composition and process of preparation
DE69705744T2 (de) Artikel mit superlegierungsubstrat und einer anreicherungsschicht darauf, sowie verfahren zu dessen herstellung
NO20023020D0 (no) Produksjon av et legeme som inneholder en elektrisk strömförende bane
DK0812235T3 (da) Fremgangsmåde til fremstilling af granulater og de således opnåede granulater
DE60002089D1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
CA2259407A1 (en) Drug delivery devices and process of manufacture
ATE226397T1 (de) Verfahren zum überziehen von käse und nach diesem verfahren hergestellte beschichtete käse
KR987000980A (en) Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient